PL3894410T3 - Podstawione pochodne ksantyny - Google Patents
Podstawione pochodne ksantynyInfo
- Publication number
- PL3894410T3 PL3894410T3 PL19820718.5T PL19820718T PL3894410T3 PL 3894410 T3 PL3894410 T3 PL 3894410T3 PL 19820718 T PL19820718 T PL 19820718T PL 3894410 T3 PL3894410 T3 PL 3894410T3
- Authority
- PL
- Poland
- Prior art keywords
- xanthine derivatives
- substituted xanthine
- substituted
- derivatives
- xanthine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18212060 | 2018-12-12 | ||
| PCT/EP2019/084375 WO2020120450A1 (en) | 2018-12-12 | 2019-12-10 | Substituted xanthine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3894410T3 true PL3894410T3 (pl) | 2024-03-18 |
Family
ID=64665184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19820718.5T PL3894410T3 (pl) | 2018-12-12 | 2019-12-10 | Podstawione pochodne ksantyny |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11198696B2 (pl) |
| EP (1) | EP3894410B1 (pl) |
| JP (1) | JP7502299B2 (pl) |
| KR (1) | KR102877857B1 (pl) |
| CN (1) | CN113166151B (pl) |
| AU (1) | AU2019396499B2 (pl) |
| BR (1) | BR112021008316A2 (pl) |
| CL (1) | CL2021001509A1 (pl) |
| DK (1) | DK3894410T3 (pl) |
| EA (1) | EA202191588A1 (pl) |
| ES (1) | ES2964630T3 (pl) |
| HU (1) | HUE064908T2 (pl) |
| IL (1) | IL283768B2 (pl) |
| MX (1) | MX2021007019A (pl) |
| PH (1) | PH12021551345A1 (pl) |
| PL (1) | PL3894410T3 (pl) |
| TW (1) | TWI825243B (pl) |
| WO (1) | WO2020120450A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12064917B2 (en) | 2012-11-21 | 2024-08-20 | Stratasys, Inc. | Method for printing three-dimensional parts with cyrstallization kinetics control |
| JP7502299B2 (ja) * | 2018-12-12 | 2024-06-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換キサンチン誘導体 |
| KR20250141831A (ko) * | 2023-02-08 | 2025-09-29 | 상하이 인스티튜트 오브 마테리아 메디카 차이니즈 아카데미 오브 싸이언시즈 | 잔틴계 화합물 및 이의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2899646C (en) | 2013-03-15 | 2021-08-31 | Hydra Biosciences, Inc. | Substituted xanthines and methods of use thereof |
| JP6667093B2 (ja) * | 2014-08-11 | 2020-03-18 | ハイドラ・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーHydra Biosciences, LLC | ピリド[2,3−d]ピリミジン−2,4(1H,3H)−ジオン誘導体 |
| GB201702160D0 (en) * | 2017-02-09 | 2017-03-29 | Univ Leeds Innovations Ltd | Inhibitors for use in therapy |
| SI3652176T1 (sl) * | 2017-07-11 | 2022-04-29 | Boehringer Ingelheim International Gmbh | Substituirani ksantinski derivati |
| JP7502299B2 (ja) * | 2018-12-12 | 2024-06-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換キサンチン誘導体 |
-
2019
- 2019-12-10 JP JP2021533340A patent/JP7502299B2/ja active Active
- 2019-12-10 PH PH1/2021/551345A patent/PH12021551345A1/en unknown
- 2019-12-10 ES ES19820718T patent/ES2964630T3/es active Active
- 2019-12-10 DK DK19820718.5T patent/DK3894410T3/da active
- 2019-12-10 EP EP19820718.5A patent/EP3894410B1/en active Active
- 2019-12-10 EA EA202191588A patent/EA202191588A1/ru unknown
- 2019-12-10 IL IL283768A patent/IL283768B2/en unknown
- 2019-12-10 MX MX2021007019A patent/MX2021007019A/es unknown
- 2019-12-10 BR BR112021008316-2A patent/BR112021008316A2/pt unknown
- 2019-12-10 PL PL19820718.5T patent/PL3894410T3/pl unknown
- 2019-12-10 AU AU2019396499A patent/AU2019396499B2/en active Active
- 2019-12-10 KR KR1020217021875A patent/KR102877857B1/ko active Active
- 2019-12-10 CN CN201980081737.1A patent/CN113166151B/zh active Active
- 2019-12-10 HU HUE19820718A patent/HUE064908T2/hu unknown
- 2019-12-10 WO PCT/EP2019/084375 patent/WO2020120450A1/en not_active Ceased
- 2019-12-11 US US16/710,887 patent/US11198696B2/en active Active
- 2019-12-12 TW TW108145593A patent/TWI825243B/zh active
-
2021
- 2021-06-09 CL CL2021001509A patent/CL2021001509A1/es unknown
- 2021-11-10 US US17/523,316 patent/US20220177479A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL283768B1 (en) | 2024-01-01 |
| HUE064908T2 (hu) | 2024-04-28 |
| IL283768B2 (en) | 2024-05-01 |
| EP3894410B1 (en) | 2023-10-11 |
| EA202191588A1 (ru) | 2021-10-18 |
| CN113166151B (zh) | 2023-12-01 |
| WO2020120450A1 (en) | 2020-06-18 |
| ES2964630T3 (es) | 2024-04-08 |
| US20200190093A1 (en) | 2020-06-18 |
| BR112021008316A2 (pt) | 2021-08-03 |
| US11198696B2 (en) | 2021-12-14 |
| KR20210102955A (ko) | 2021-08-20 |
| TWI825243B (zh) | 2023-12-11 |
| JP2022512373A (ja) | 2022-02-03 |
| TW202039495A (zh) | 2020-11-01 |
| CL2021001509A1 (es) | 2021-12-17 |
| EP3894410A1 (en) | 2021-10-20 |
| AU2019396499A1 (en) | 2021-05-27 |
| CA3119229A1 (en) | 2020-06-18 |
| US20220177479A1 (en) | 2022-06-09 |
| CN113166151A (zh) | 2021-07-23 |
| JP7502299B2 (ja) | 2024-06-18 |
| PH12021551345A1 (en) | 2022-05-11 |
| AU2019396499B2 (en) | 2024-10-10 |
| KR102877857B1 (ko) | 2025-10-29 |
| MX2021007019A (es) | 2021-09-10 |
| DK3894410T3 (da) | 2023-11-27 |
| IL283768A (en) | 2021-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283197A (en) | Microbiocidal 2-acylamino-thiazole-4-carboxamide derivatives | |
| PT3958977T (pt) | Derivados de camptotecina | |
| IL283333A (en) | New heterocyclic compounds | |
| IL292161A (en) | New methylquinazolinone derivatives | |
| PL3897842T3 (pl) | Pochodne bicykliczne | |
| LT3830085T (lt) | Deuterinti lanifibranoro dariniai | |
| DK3642202T3 (da) | Dihydro-pyrrolo-pyridin-derivater | |
| DK3810587T3 (da) | Substituerede alkoxypyridinylindolsulfonamider | |
| LT3768674T (lt) | Aminopirimidino dariniai kaip ctps1 inhibitoriai | |
| EP4013751C0 (en) | 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES | |
| IL265166B (en) | Anti-influenza virus pyrimidine derivatives | |
| DK3768669T3 (da) | Piperazinazaspiroderivater | |
| EP4077334C0 (en) | FUROINDAZOLE DERIVATIVES | |
| LT3402792T (lt) | Chinolin-2-ono dariniai | |
| EP4021904C0 (en) | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | |
| LT3457851T (lt) | Sobetiromo dariniai | |
| EP3862116A4 (en) | Lathe | |
| DK3823970T3 (da) | Yderligere substituerede triazoloquinoxalinderivater | |
| EP3884940A4 (en) | Novel imidazole derivative | |
| DK3823971T3 (da) | Substituerede triazol-quinoxalin-derivater | |
| DK3652176T3 (da) | Substituerede xanthinderivater | |
| PL3898637T3 (pl) | Pochodne rapamycyny | |
| EP3885347A4 (en) | DIHYDROPYRROLOPYRAZOLE DERIVATIVE | |
| DK3796975T3 (da) | Sulfonylaminobenzamidderivater | |
| PL3894410T3 (pl) | Podstawione pochodne ksantyny |